Literature DB >> 33185278

Impact of root canal treatment on high-sensitivity C-reactive protein levels in systemically healthy adults with apical periodontitis - a preliminary prospective, longitudinal interventional study.

L Poornima1, P Ravishankar1, P V Abbott2, A Subbiya3, A R PradeepKumar1.   

Abstract

AIM: To assess the influence of root canal treatment on serum high-sensitivity C-reactive protein (hsCRP) levels in systemically healthy human adults.
METHODOLOGY: Fifteen individuals aged 20-40 years diagnosed with apical periodontitis [Periapical Index (PAI) score ≥3] who were otherwise healthy took part in this prospective interventional study. Patients with moderate to severe periodontitis, systemic diseases and traditional cardiac risk factors (hypertension, diabetes, dyslipidemia and smoking) were excluded. Root canal treatment was completed in two visits with an inter-appointment calcium hydroxide intracanal medicament. After 6 months, healing of apical periodontitis was evaluated clinically and radiographically, and serum hsCRP levels were recorded. A paired sample T-test was used to compare the mean hsCRP values between the pre- and post-treatment groups. The Mann-Whitney U test was used to compare hsCRP values between patients with PAI scores of 3 and 4, and the Wilcoxon signed-rank test was used to compare pre- and postoperative PAI scores.
RESULTS: The mean preoperative baseline serum hsCRP level was 2.88 ± 1.06 mg L-1 which can be associated with a moderate risk for cardiovascular disease (CVD). Based on the preoperative hsCRP levels, eight of the 15 patients were categorized as high risk (hsCRP > 3 mg L-1 ) and the other seven as medium risk (hsCRP 1-3 mg L-1 ) for CVD. The mean preoperative hsCRP value of patients with a PAI score of 3 was 2.88 ± 1.19 mg L-1 , and the mean preoperative hsCRP of patients with a PAI score of 4 was 2.87 ± 0.15 mg L-1 , which was not significantly different (P = 0.942). Six months after root canal treatment, the mean PAI score had significantly reduced from 3.2 ± 0.42 to 1.4 ± 0.69 (P = 0.003). The PAI score had reduced to ≤2 in 87% of the patients, and the mean serum hsCRP levels had significantly reduced to 1.34 ± 0.52 mg L-1 (P < 0.001). Ten of the 15 patients had a reduction in their CVD risk status.
CONCLUSIONS: This study suggests that root canal treatment can reduce serum hsCRP levels in systemically healthy individuals with apical periodontitis.
© 2020 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  apical periodontitis; cardiovascular risk; root canal treatment; serum hsCRP

Year:  2020        PMID: 33185278     DOI: 10.1111/iej.13444

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  4 in total

Review 1.  Evolution of endodontic medicine: a critical narrative review of the interrelationship between endodontics and systemic pathological conditions.

Authors:  Luciano Tavares Angelo Cintra; Maximiliano Schünke Gomes; Cristiane Cantiga da Silva; Flávio Duarte Faria; Francine Benetti; Leopoldo Cosme-Silva; Renata Oliveira Samuel; Tiago Novaes Pinheiro; Carlos Estrela; Alvaro Cruz González; Juan José Segura-Egea
Journal:  Odontology       Date:  2021-07-08       Impact factor: 2.634

2.  Expression of IL-6, TNF-α, and hs-CRP in the serum of patients undergoing single-sitting and multiple-sitting root canal treatment: A comparative study.

Authors:  Rohit Agrawal; Monika Bhardwaj; Bonita Doley; Abhigyan Manas; Prabu Mahin Syed Ismail; Prajakta B Patil; Kishore K Singh
Journal:  J Family Med Prim Care       Date:  2022-05-14

Review 3.  Association between Endodontic Infection, Its Treatment and Systemic Health: A Narrative Review.

Authors:  Sadia Ambreen Niazi; Abdulaziz Bakhsh
Journal:  Medicina (Kaunas)       Date:  2022-07-14       Impact factor: 2.948

4.  The impact of apical periodontitis, non-surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers.

Authors:  Abdulaziz Bakhsh; David Moyes; Gordon Proctor; Francesco Mannocci; Sadia Ambreen Niazi
Journal:  Int Endod J       Date:  2022-06-27       Impact factor: 5.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.